Home | Welcome to Contract Pharma   
Last Updated Saturday, December 20 2014

Print RSS Feed

Search Results for 'Financial Report: Alexion'

Search For:
Refine by Dates:
From: To:
Past 7 Days        Past 30 Days
Refine By Content:

Search Results:

Published October 23, 2014
Soliris sales up 39% in the quarter Read More »
Published April 24, 2014
Solaris revenue up 67% in the quarter Read More »
By Gil Roth
Published January 30, 2014
Soliris sales continue to climb Read More »
Published July 18, 2013
To develop candidates targeting severe and rare disorders Read More »
Published February 14, 2013
Solaris sales climb 41% in the quarter Read More »
Published October 24, 2012
Revenues up 44% in the quarter Read More »
Published July 21, 2011
Soliris sales jump 48% to $185.7 million. Read More »
Solaris revenue up 67% in the quarter Read More »
Published November 19, 2014
Graff brings extensive drug discovery and development experience Read More »
Published October 15, 2014
Will perform drug combination screening on lead oncology asset Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On